MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/advs.77153

Медицинская библиотека · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

Multi-Omics Integration Identifies a CDH3-Associated Malignant Epithelial State and Immunosuppressive Niche to Predict Prognosis in Thymic Epithelial Tumors.

Feng Yuntao, Chen Jingyu, Xia Lang, Wang Tao, Wang Yuzhou, Zhang Lei, Zhao Guofang, Xu Long, Yu Juemin, She Yunlang, Wu Junqi, Zhao Yue, Chen Chang, Zhao Deping

СтатьяПеревод пока не подготовлен

Аннотация

Thymic epithelial tumors (TETs) are rare and heterogeneous malignancies whose aggressive epithelial states and microenvironmental organization remain poorly defined. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, multiplex immunofluorescence, bulk transcriptomics, functional assays, xenograft validation, and computational pathology to characterize malignant epithelial heterogeneity in TETs. We identified a CDH3-associated malignant epithelial state located at the origin of malignant-state trajectories and enriched for stem-like and EMT-related features. Spatial transcriptomics and multiplex immunofluorescence showed that CDH3+ tumor cells preferentially localized within an M2 macrophage-rich immunosuppressive niche, while cell-cell communication analyses nominated CCN2-LRP1 as a candidate epithelial-myeloid crosstalk axis. A 68-gene CDH3-associated signature stratified TCGA-THYM into biologically distinct subgroups with differences in survival, histology, genomic instability, and immune contexture. Patient-derived thymic carcinoma organoids showed elevated CDH3 expression, and CDH3 silencing suppressed thymic carcinoma cell proliferation, migration, invasion, EMT/PI3K-Akt-related signaling, and macrophage-associated crosstalk. Candidate inhibitors showed antitumor activity in xenograft models. We also established a deep learning pathology model that captured CDH3-associated morphology from routine H&E slides and predicted patient outcome. Together, these findings define CDH3 as a biomarker and therapeutic target linking malignant epithelial plasticity to immunosuppressive niche formation and adverse clinical behavior in TETs.

Для цитирования: Feng Yuntao, Chen Jingyu, Xia Lang, Wang Tao, Wang Yuzhou, Zhang Lei, Zhao Guofang, Xu Long, Yu Juemin, She Yunlang, Wu Junqi, Zhao Yue, Chen Chang, Zhao Deping. Multi-Omics Integration Identifies a CDH3-Associated Malignant Epithelial State and Immunosuppressive Niche to Predict Prognosis in Thymic Epithelial Tumors.. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2026. DOI: 10.1002/advs.77153.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.